MARK2 and colorectal carcinoma: In this regard, oncogenic mutations in GTPase proteins of the RAS family, as well as in the serine/threonine kinase BRAF, stand out as underlying conditions for proliferative autonomy in 52 and 10% of all CRC cases, respectively [48,49].